Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection

Journal of Investigative Dermatology

Volumn 132, Issue 5, 2012, Pages 1425-1434

  Tian, Tian ^a   Dubin, Krista ^b   Jin, Qiushuang ^c   Qureshi, Ali ^d   King, Sandra L ^a   Liu, Luzheng ^a   Jiang, Xiaodong ^a   Murphy, George F ^a   Kupper, Thomas S ^a   Fuhlbrigge, Robert C ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; LYMPH NODE; MOUSE; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; SCAR; SKIN CELL; SKIN INFECTION; SPLEEN; VACCINIA VIRUS; VACCINIA VIRUS INFECTION; VIRUS IMMUNITY;

EID: 84862829170     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.489     Document Type: Article

References (26)

1. Engler RJ, Kenner J, Leung DY (2002) Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 110:357-65
2. Faustman D, Davis M (2010) TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev 9:482-93
3. Freyschmidt EJ, Mathias CB, Diaz N et al. (2010) Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses. J Immunol 185:1295-302
4. Howell MD, Gallo RL, Boguniewicz M et al. (2006) Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24:341-8
5. Howell MD, Jones JF, Kisich KO et al. (2004) Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 172:1763-7 (Pubitemid 38116824)
6. Kock A, Schwarz T, Kirnbauer R et al. (1990) Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609-14
7. Liu L, Fuhlbrigge RC, Karibian K et al. (2006) Dynamic programming of CD8+ T cell trafficking after live viral immunization. Immunity 25:511-20 (Pubitemid 44354216)
8. Liu L, Xu Z, Fuhlbrigge RC et al. (2005) Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. J Virol 79:7363-70 (Pubitemid 40756772)
9. Liu L, Zhong Q, Tian T et al. (2010) Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med 16:224-7
10. Lundberg P, Welander PV, Edwards III CK et al. (2007) Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virusinduced encephalitis independently of signaling via TNF receptor 1 or 2. J Virol 81:1451-60 (Pubitemid 46167866)
11. McClain DJ, Harrison S, Yeager CL et al. (1997) Immunologic responses to vaccinia vaccines administered by different parenteral routes. J Infect Dis 175:756-63 (Pubitemid 27142945)
12. Nestle FO, Di Meglio P, Qin JZ et al. (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9:679-91
13. Nie S, Cornberg M, Selin LK (2009) Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity. J Immunol 183:6554-60
14. Poulin LF, Henri S, de Bovis B et al. (2007) The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 204:3119-31
15. Reading PC, Khanna A, Smith GL (2002) Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology 292:285-98 (Pubitemid 34920548)
16. Rimoin AW, Mulembakani PM, Johnston SC et al. (2010) Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci USA 107:16262-7
17. Rouse BT, Sarangi PP, Suvas S (2006) Regulatory T cells in virus infections. Immunol Rev 212:272-86 (Pubitemid 44116714)
18. Ruby J, Bluethmann H, Peschon JJ (1997) Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J Exp Med 186:1591-6 (Pubitemid 27479819)
19. Sambhi SK, Kohonen-Corish MR, Ramshaw IA (1991) Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci USA 88:4025-9 (Pubitemid 21916757)
20. Schluter D, Deckert M (2000) The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Infect 2:1285-92
21. Seet BT, Johnston JB, Brunetti CR et al. (2003) Poxviruses and immune evasion. Ann Rev Immunol 21:377-423 (Pubitemid 37174536)
22. Singh A, Suresh M (2007) A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory. J Leukoc Biol 82:1201-11 (Pubitemid 350133518)
23. Street M, Coulson PS, Sadler C et al. (1999) TNF is essential for the cellmediated protective immunity induced by the radiation-attenuated schistosome vaccine. J Immunol 163:4489-94 (Pubitemid 29474518)
24. Tian T, Liu L, Freyschmidt EJ et al. (2009) Overexpression of IL-1alpha in skin differentially modulates the immune response to scarification with vaccinia virus. J Invest Dermatol 129:70-8
25. Wang B, Kondo S, Shivji GM et al. (1996) Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells. Immunology 88:284-8 (Pubitemid 26189312)
26. Zganiacz A, Santosuosso M, Wang J et al. (2004) TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 113:401-13 (Pubitemid 38544184)